ZLAB · Zai Lab Ltd
$18.31
-0.31 (-1.66%)
At close · Jul 29
View the 10-Q filed May 7, 2026
Customer concentration
— top customer 25% of receivables
One customer — 25% of receivables (As of March 31, 2026)
“As of March 31, 2026, our largest customer accounted for approximately 25% of our total accounts receivable collectively.”
Market Cap
$27.26B
Shares
1.46B
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Rafael Amado | President and Head of Global Development Oncology | $4,010,205 |
| Yajing Chen | CFO | $3,185,488 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Rafael Amado | President and Head of Global Development Oncology | $3,645,791 |
| Yajing Chen | CFO | $2,625,170 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Joshua Smiley | COO | $5,550,550 |
| Josh Smiley | COO | $5,550,550 |
| Rafael Amado | President and Head of Global Development Oncology | $4,865,822 |
| Billy Cho | CFO | $2,886,001 |
| Yajing Chen | CFO | $2,014,532 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Josh Smiley | COO | $8,296,517 |
| Joshua Smiley | COO | $8,296,517 |
| Rafael Amado | President and Head of Global Development Oncology | $7,501,706 |
| Alan Bart Sandler | Chief Development Officer | $7,329,748 |
| Billy Cho | CFO | $4,381,180 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Harald Reinhart | President and Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases | $8,212,040 |
| Alan Bart Sandler | Chief Development Officer | $6,622,039 |
| F. Ty Edmondson | Chief Legal Officer | $5,629,054 |
| Billy Cho | CFO | $4,243,676 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Alan Bart Sandler | Chief Development Officer | $7,063,890 |
| F. Ty Edmondson | Chief Legal Officer | $4,408,928 |
| Billy Cho | CFO | $1,484,163 |
| Tao Fu | COO | $649,770 |
Key facts
CIK
1704292
CUSIP
98887Q104
13F (30d)
25 filings
13 filers
Visit website
Investor relations